NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 649574 | Null | 0.035202825328704 | 0.188868 |
NSC 650363 | Null | 0.035202825328704 | 0.10743005 |
NSC 658855 | Null | 0.035202825328704 | -0.18446538 |
NSC 670121 | 11-Hydroxy aclacinomycin A | 0.035202825328704 | 0.31045507 |
NSC 692303 | 2,3-Dihydro-3(R)-[4'hydroxyphenylsulfinyl]brefeldin A | 0.035202825328704 | -0.08542732 |
NSC 693037 | Null | 0.035202825328704 | 0.1116929 |
NSC 709358 | 1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol | 0.035202825328704 | -0.026791949 |
NSC 717468 | Null | 0.035202825328704 | -0.14672182 |
NSC 718630 | Null | 0.035202825328704 | 0.44743663 |
NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.035202825328704 | 0.16348705 |